CABALETTA BIO INC (CABA)
US12674W1099 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 193.24M | 81.60M | 122.20M | 101.40M | 136.20M | |||
| Marketable Securities | 48.01M | 24.90M | 0.00 | 7.20M | N/A | |||
| Other Current Assets | 3.24M | 2.30M | 2.30M | 4.90M | 4.30M | |||
| Total Current Assets | 244.49M | 108.80M | 124.50M | 113.50M | 140.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.45M | 7.60M | 1.40M | 900.00K | 800.00K | |||
| Other Non-Current Assets | 1.71M | 600.00K | 400.00K | 300.00K | 100.00K | |||
| Total Non-Current Assets | 9.16M | 8.20M | 1.80M | 1.20M | 900.00K | |||
| TOTAL ASSETS | 253.65M | 117.00M | 126.30M | 114.70M | 141.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.76M | 5.70M | 3.00M | 2.40M | 1.50M | |||
| Accounts Payable | 4.55M | 2.50M | 2.30M | 1.20M | 900.00K | |||
| Other Current Liabilities | 2.69M | 1.30M | 3.10M | 1.50M | 700.00K | |||
| Total Current Liabilities | 15.99M | 9.50M | 8.40M | 5.20M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.46M | 3.00M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 1.46M | 2.90M | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 17.45M | 12.40M | 8.40M | 5.20M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -233.24M | -165.60M | -112.60M | -66.30M | -33.00M | |||
| Additional Paid In Capital | 469.40M | 270.10M | 230.50M | 175.80M | 171.30M | |||
| Common Shares | 480.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 38.52K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 47.82M | 29.40M | 28.90M | 24.10M | 24.00M | |||
| Tangible Book Value per Share | 4.94 | 3.55 | 4.08 | 4.54 | 5.76 | |||
| Total Shareholders' Equity | 236.20M | 104.50M | 118.00M | 109.50M | 138.30M | |||
| TOTAL LIABILITIES AND EQUITY | 253.65M | 117.00M | 126.30M | 114.70M | 141.50M | |||
| Statistics | ||||||||
| Current Ratio | 15.29 | 11.45 | 14.82 | 21.83 | 45.35 | |||
| Return On Assets (ROA) | -26.68% | -45.28% | -36.65% | -29.07% | -15.74% | |||
| Return On Equity (ROE) | -28.65% | -50.70% | -39.23% | -30.45% | -16.10% | |||
All data in USD